Myasthenia Gravis Treatment Market Size, Regional Outlook, Competitive Landscape, Revenue Analysis & Forecast Till 2030 The myasthenia gravis treatment market size reached USD 1.24 Billion in 2021 and is expected to register a revenue CAGR of 7.5% during the forecast period. Global rise in prevalence of the disease is one of the main factors driving the myasthenia gravis treatment market revenue growth. Read More: https://www.emergenresearch.com/industry-report/myasthenia-gravis-treatment-market For instance, the global prevalence of myasthenia gravis disease is estimated to be 12.4 individuals (95% CI 10.6-14.5) per 100,000 of the population. The number of myasthenia gravis patients is increasing, accounting more than doubled in the previous 20 years. This increase is mostly attributable to a higher disease incidence among the elderly, which is owing to improved diagnosis, treatment, as well as population longevity.